<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03556488</url>
  </required_header>
  <id_info>
    <org_study_id>13528/18</org_study_id>
    <nct_id>NCT03556488</nct_id>
  </id_info>
  <brief_title>Ultrasonographic Air Bronchogram in Pediatric CAP</brief_title>
  <acronym>USINCHILD</acronym>
  <official_title>Prognostic Role of Ultrasonographic Air Bronchogram in the Management of Community Acquired Pneumoniae in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catholic University of the Sacred Heart</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Catholic University of the Sacred Heart</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the prognostic role of the change of arborescent air bronchogram, a
      typical ultrasonographic finding of lung consolidation due to pneumonia, in the management of
      pediatric CAP.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single-center prospective study to evaluate the prognostic role of the change of
      arborescent air bronchogram, a typical ultrasonographic finding of lung consolidation due to
      pneumonia, in the management of CAP in terms of: 1) impact on rate of uncomplicated
      respiratory infections [rate of uncomplicated CAP], 2) relationship to the time of resolution
      of clinical signs [time to resolution of fever], 3) change of antibiotic therapy not guided
      by microbiological examinations and, 4) length of hospitalization.

      At admission, the Pediatric will evaluate clinical signs of respiratory distress, request
      microbiologic tests (nasopharyngeal swab specimens and pneumococcal urinary antigen) to
      detect causative pathogens of CAP, and laboratory tests (complete blood cell count,
      acute-phase reactants C-reactive protein). Finally, all children will undergo chest
      radiography (CXR). If CXR should be performed before the admission to Pediatric Unit, the
      radiological exam will be not repeated.

      Ultrasonographic evaluation will be performed by Pulmonologists. The first examination will
      be performed within 12 hours from admission. The Pulmonologists will be blind to clinical and
      radiological data.

      In order to characterize the lung consolidation, a grading system based on the presence and
      the features of air bronchogram [static, dynamic, dynamic with areas of lung recruitment]
      will be adopted. The operator will collect and store images and videos (10seconds), these
      findings will be reviewed by an expert Clinician in chest US blind to other data.

      After 48h from the admission, all children will undergo follow-up laboratory tests and lung
      US.

      In case of clinical deterioration, children will undergo further ultrasonographic evaluations
      according pediatric indications.

      Finally, all children will undergo lung US after 7 Â± 2 days from discharge.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 21, 2018</start_date>
  <completion_date type="Anticipated">September 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of uncomplicated CAP</measure>
    <time_frame>48 hours</time_frame>
    <description>Impact on rate of uncomplicated respiratory infections</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to resolution of fever</measure>
    <time_frame>Through study completion, an average of 7 days.</time_frame>
    <description>Relationship to the time of resolution of clinical signs</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of antibiotic therapy</measure>
    <time_frame>48 hours</time_frame>
    <description>Change of antibiotic therapy not guided by microbiological examinations</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Length of hospitalization</measure>
    <time_frame>Through study completion, an average of 10 days.</time_frame>
    <description>Length of hospitalization</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Pneumonia</condition>
  <condition>Pediatric Infectious Disorder</condition>
  <arm_group>
    <arm_group_label>Pediatric CAP</arm_group_label>
    <description>Patients with a clinical diagnosis of CAP and radiographic evidence of lung consolidation, hospitalized in the Pediatric Unit.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>US air bronchogram score</intervention_name>
    <description>On ultrasonographic examination, lung consolidation is defined as a subpleural echo-poor region or one with tissue- like echotexture, depending on the extent of air loss and fluid predominance, which is clearly different from the normal pattern.
The air bronchogram is characterized as: absent, static, dynamic, dynamic with areas of lung recruitment.</description>
    <arm_group_label>Pediatric CAP</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a clinical diagnosis of CAP and radiographic evidence of lung consolidation.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Suspected CAP

          -  Age from 1 to 16 years old

          -  Admission to Pediatric Unit

          -  Radiographic evidence of lung consolidation

          -  Written informed consent from parents

        Exclusion Criteria:

          -  Gestational age &lt; 36 weeks

          -  Previous diagnosis of cystic fibrosis

          -  Congenital pulmonary disease.

          -  Refusal to participate.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luca Richeldi, Prof,MD,PhD</last_name>
    <role>Study Director</role>
    <affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Riccardo Inchingolo, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Riccardo Inchingolo, MD, PhD</last_name>
    <phone>+390630154236</phone>
    <email>riccardo.inchingolo@policlinicogemelli.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fondazione Policlinico Universitario A. Gemelli</name>
      <address>
        <city>Roma</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Riccardo Inchingolo, M.D., Ph.D.</last_name>
      <phone>+0630154236</phone>
      <email>riccardo.inchingolo@policlinicogemelli.it</email>
    </contact>
    <investigator>
      <last_name>Rafael Emanuele Gerardi, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Smargiassi, M.D., Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emanuele Conte, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antonio Gatto, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Piero Valentini, Prof., M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chiara Pierandrei, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lavinia Capossela, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Giuseppe M Corbo, Prof., M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Sanitaria Universitaria Integrata di Trieste - Ospedale di Cattinara</name>
      <address>
        <city>Trieste</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto Copetti, M.D.</last_name>
      <email>robcopet@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Roberto Copetti, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>June 4, 2018</study_first_submitted>
  <study_first_submitted_qc>June 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2018</study_first_posted>
  <last_update_submitted>February 2, 2020</last_update_submitted>
  <last_update_submitted_qc>February 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Catholic University of the Sacred Heart</investigator_affiliation>
    <investigator_full_name>Riccardo Inchingolo</investigator_full_name>
    <investigator_title>Physician and clinical researcher</investigator_title>
  </responsible_party>
  <keyword>Chest ultrasound</keyword>
  <keyword>Pediatric community acquired pneumonia</keyword>
  <keyword>Air bronchogram</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infection</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

